Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/24 16:31 | 9/16/24 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Tang Kevin | CA | T | P.m | 1,806 | 14.75 | 0 | 122 | 49 | 372 | I | |||||||||||||||
11/20/23 16:31 | 11/16/23 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Spaventa Andrew | CA | DO | CEO | P.m | 50 | 0.4188 | 0 | 118 | 3 | 4,071 | I | ||||||||||||||
11/20/23 16:30 | 11/16/23 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Glezer Eli N. | CA | O | Chief Sc | P | 86 | 0.4282 | 0 | 200 | 5 | 4,570 | D | ||||||||||||||
5/18/23 20:32 | 5/17/23 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Glezer Eli N. | CA | O | Chief Sc | P | 139 | 0.8172 | 0 | 170 | 4 | 4,355 | D | ||||||||||||||
12/13/22 18:14 | 12/12/22 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Glezer Eli N. | CA | O | Chief Sc | P | 100 | 2.00 | 0 | 50 | 1 | 4,185 | D | ||||||||||||||
5/19/22 17:01 | 5/18/22 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Pellini Michael J | CA | D | P | 89 | 3.30 | 0 | 27 | 16 | 196 | D | |||||||||||||||
6/3/21 17:04 | 6/1/21 | OMIC | Electr | LabEq | Laboratory Analytical Instrum | Flynn James E | NY | TH | *Possibl | P.d | 33,000 | 22.00 | 0 | 1,500 | 20 | 9,112 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |